Form 4: WisdomTree COO Sells Shares Under Pre-Arranged Plan

WisdomTree's President and COO, R Jarrett Lilien, sold 12,500 shares of common stock for $11.01 per share under a pre-arranged 10b5-1 trading plan.

Summary

• R Jarrett Lilien, President and COO of WisdomTree, Inc. (WT), reported a sale of common stock.
• The transaction involved the disposition of 12,500 shares of WisdomTree common stock.
• The shares were sold at a price of $11.01 per share.
• The sale was executed on November 25, 2025.
• Following this transaction, Lilien beneficially owns 998,638 shares of common stock.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan established on February 25, 2025, indicating no discretion over the timing of the transaction.
• Lilien's beneficial ownership includes restricted stock awards vesting as follows: 155,950 shares on January 25, 2026; 90,787 shares on January 25, 2027; and 35,941 shares on January 25, 2028.

Sentiment

Score: 5

Explanation: The sale is neutral as it was pre-planned under a 10b5-1 plan, indicating no discretionary timing based on recent events. The executive retains significant ownership, including future vesting awards.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, which indicates a pre-scheduled transaction and not a reaction to recent company performance or news.
• The reporting person still retains a significant beneficial ownership of 998,638 shares, including substantial restricted stock awards, aligning interests with shareholders.

Negatives

• An insider sale, even under a 10b5-1 plan, represents a reduction in direct ownership by a key executive.

Risks

• While a 10b5-1 plan mitigates the immediate negative signal of an insider sale, it still represents an executive diversifying their holdings, which could be interpreted by some investors as a lack of conviction, though this is less likely given the pre-planned nature.
• All sales by the reporting person are subject to the Issuer's equity ownership requirements, implying potential future sales if those requirements are met or exceeded.

Future Outlook

The filing indicates future vesting dates for restricted stock awards on January 25, 2026, January 25, 2027, and January 25, 2028, which will add to the reporting person's exercisable shares over time.

Management Comments

• The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on February 25, 2025. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
• All sales by the reporting person are subject to the Issuer's equity ownership requirements.

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are common in the financial industry as executives manage their personal portfolios and liquidity needs while adhering to insider trading regulations. These pre-arranged plans help mitigate concerns about executives trading on material non-public information.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan aligns with best practices for corporate executives to manage their equity holdings in a compliant and transparent manner, similar to practices seen at other publicly traded financial services firms like BlackRock or Invesco.
• The retained beneficial ownership of nearly one million shares, including significant restricted stock awards, suggests a continued alignment of the executive's interests with long-term shareholder value, comparable to equity retention levels often observed among senior management at peer companies.

Corporate Governance

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but mitigated by the pre-planned nature of the sale and the executive's continued substantial holdings, including future vesting awards.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Vesting of 155,950 restricted stock awards on January 25, 2026.
• Vesting of 90,787 restricted stock awards on January 25, 2027.
• Vesting of 35,941 restricted stock awards on January 25, 2028.

Key Dates

Recommendation

The Form 4 filing details a pre-scheduled insider sale under a 10b5-1 plan, which is a routine event for executives managing their personal finances and does not typically signal a change in company fundamentals or outlook. The executive retains a substantial equity stake, including future vesting awards. Therefore, this specific filing alone does not warrant a change in investment recommendation, and a 'hold' stance is appropriate based solely on this information.

Keywords

WisdomTree, WT, R Jarrett Lilien, Insider Trading, Form 4, SEC Filing, Stock Sale, 10b5-1 Plan, Executive Compensation, Common Stock, Restricted Stock Awards